Bausch Health Companies | VRX - Nettoeinkommen

Aktienkurs
6.84
Täglich Wechseln
-0.18 -2.56%
Monatlich
-18.28%
Jährlich
-31.60%
Q1 Prognose
6.73




Nettoeinkommen Veränderung Datum
Amgen USD 1.33B 1.88B 2025-12
ANI Pharmaceuticals USD 32.35M 6.08M 2025-12
Aurora Cannabis CAD 1.82M 53.29M 2025-12
Bausch Health Companies USD -112M 291M 2025-12
Biogen USD 466.5M 168.3M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Canopy Growth CAD -62.63M 60.99M 2025-12
Corcept Therapeutics USD 24.29M 4.62M 2025-12
Danaher USD 1.2B 289M 2025-12
Drreddys Laboratories INR 12.1B 2.08B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Novo Nordisk DKK 26.89B 388M 2025-12
Pacira USD 1.64M 3.8M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Zoetis USD 603M 118M 2025-12